Skip to content

Sellas Life Sciences

US · SLS #2687 by market cap Listed 1970
11.31 -0.03 -0.26%
Live - 5344 symbols - heartbeat 45s ago · 2026-10-08 07:00
Pre-market 11.31 0.00%
After-hours 11.35 +0.35%
Overnight 11.32 +0.09%
Market cap
2.28B
P/B
16.58
EPS
-0.25
Reader sentiment Are you bullish or bearish on SLS?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $10
    Market Newswire · 2026/5/15
  • Rating change
    Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Raises Target Price to $10
    Market Newswire · 2026/3/14
  • Rating change
    Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $4
    Market Newswire · 2025/2/22
  • Rating change
    A. G. P. Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $7.5
    Market Newswire · 2025/11/18
  • Rating change
    Analysts Offer Insights on Healthcare Companies: SELLAS Life Sciences Group (SLS) and Maze Therapeutics, Inc. (MAZE)
    TipRanks · 2025/12/31
  • Pre-Market Movement | SLS.US Stock Price Fluctuates Amid Multiple News Items
    Market Newswire · 2026/6/3
  • Rating change
    Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $7
    Market Newswire · 2025/12/31
  • Rating change
    A. G. P. Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Raises Target Price to $10
    Market Newswire · 2026/3/20
  • Company notice
    Syra Health Corp. | 3: Initial statement of beneficial ownership of securities-10% Owner SLS GROUP LLC
    SEC · 2023/9/29
  • Rating change
    A. G. P. Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $10
    Market Newswire · 2026/5/13
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Raises Target Price to $30
    Market Newswire · 2026/7/9
  • A. G. P. Initiates Sellas Life Sciences(SLS.US) With Buy Rating, Announces Target Price $25
    Market Newswire · 2026/7/6
  • Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $30
    Market Newswire · 2026/8/20
  • Earnings Flash (SLS) SELLAS Life Sciences Posts Q2 Loss $0.05, Vs. FactSet Est of $0.05 Loss
    MT Newswires · 2026/8/12

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.